Iasn, Video game

Washington, Aug 13 (IASN) The US Food and Drug Administration (FDA) authorised both the Pfizer-BioNTech and Moderna's Covid-19 vaccine to administer an additional dose in people with weaker immune systems, which includes organ transplant recipients.The third dose will be administered at least 28 days following the two-dose regimen of the same vaccine to individuals 18 years of age or older (ages 12 or older for Pfizer-BioNTech) who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise, the agency said in a statement on Thursday.People with organ transplantation and those immunocompromised in a similar manner have a reduced ability to fight infections and other diseases, and they are especially vulnerable to infections, including Covid-19.The roll out of booster dose is based on FDA's evaluation in these individuals, according to which the administration of third vaccine doses may increase protection in this population."The country has entered yet another wave of the Covid-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease. After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna Vaccines," said Janet Woodcock, Acting FDA Commissioner, in the statement."Today's action allows doctors to boost immunity in certain immunocompromised individuals who need extra protection from Covid-19. As we've previously stated, other individuals who are fully vaccinated are adequately protected and do not need an additional dose of Covid-19 vaccine at this time. The FDA is actively engaged in a science-based, rigorous process with our federal partners to consider whether an additional dose may be needed in the future," she added.These patients should be counseled to maintain physical precautions to help prevent Covid-19. In addition, close contacts of immunocompromised persons should get vaccinated, as appropriate for their health status, to provide increased protection to their loved ones, the FDA said.The US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices is scheduled to meet on Friday to discuss further clinical recommendations regarding immunocompromised individuals.The two-shot Covid-19 vaccine developed by Pfizer-BioNTech is currently authorised for emergency use in individuals ages 12 and older and is administered three weeks apart, while the Moderna shots are authorised for emergency use in individuals ages 18 and older, administered one month apart.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

IasnFOLLOW

Iasn, Latest News

Football :Barca president denies 7-million-euro payments attempted to influence referees

Madrid, April 18 (IASN) FC Barcelona President Joan Laporta held a press conference to explain the ongoing scandal around ... ...

Technology :Galaxy M33 5G with 6000mAh battery to launch in India soon

New Delhi, March 23 (IASN) Samsung is planning to launch Galaxy M33 5G, its latest M series smartphone in ... ...

Technology :Image for Samsung unveils new range of WindFree ACs in India

New Delhi, Feb 24 (IASN) Samsung on Thursday unveiled its 2022 line-up of air conditioners with WindFree technology in ... ...

Technology :Samsung Expert RAW app expected to come to more Galaxy devices

Seoul, Feb 15 (IASN) Samsung released a new version of its Expert RAW camera app for the Galaxy S21 ... ...

National :SC declines to entertain plea seeking to extend lapsed FCRA of nearly 6K NGOs

New Delhi, Jan 25 (IASN) The Supreme Court on Tuesday declined to entertain a plea seeking an interim relief ... ...

Health :US FDA okays Covid booster dose for those with weak immune system

Washington, Aug 13 (IASN) The US Food and Drug Administration (FDA) authorised both the Pfizer-BioNTech and Moderna's Covid-19 vaccine ... ...